Complexes between C1q and C3 or C4: Novel and specific markers for classical complement pathway activation

被引:34
作者
Wouters, D
Wiessenberg, HD
Hart, M
Bruins, P
Voskuyl, A
Daha, MR
Hack, CE
机构
[1] Acad Med Ctr, Dept Immunopathol, Sanquin Res, Amsterdam, Netherlands
[2] Acad Med Ctr, Lab Expt & Clin Immunol, Amsterdam, Netherlands
[3] Univ Utrecht, Med Ctr, Dept Anaesthesiol, Utrecht, Netherlands
[4] Free Univ Amsterdam, Med Ctr, Dept Rheumatol, Amsterdam, Netherlands
[5] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Amsterdam, Netherlands
[6] Free Univ Amsterdam, Med Ctr, Dept Clin Chem, Amsterdam, Netherlands
关键词
activation products; complement; inflammation; in vitro; in vivo;
D O I
10.1016/j.jim.2004.12.018
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Classical pathway activation is often assessed by measuring circulating levels of activated C4. However, this parameter does not discriminate between activation through the classical or the lectin pathway. We hypothesized that during classical pathway activation, complexes are formed between C1q and activated C4 or C3. Using ELISA, we investigated whether such complexes constitute specific markers for classical pathway activation. In vitro, C1q-C3d/C4d complexes were generated upon incubation of normal recalcified plasma with aggregated IgG or an anti-C1q mAb that activates C1 (mAb anti-C1q-130). In contrast, during incubation with C1s or trypsin, C1q-C3d/C4d complexes were not generated, which excludes an innocent bystander effect. Additionally, C1q-C3d/C4d complexes were not generated during activation of the alternative or the lectin pathway. Repeated freezing and thawing did not influence levels of C1q-C3d/C4d complexes in recalcified plasma. To measure C1q-complement complexes in plasma samples, we separated unbound complement proteins from C1q-C3d/C4d complexes in the samples prior to testing with ELISA. In samples from patients undergoing cardiopulmonary bypass surgery or suffering from rheumatoid arthritis, we found higher levels of C1q-C4 complexes than in samples from healthy individuals. We conclude that complexes between C1q and C4 or C3 are specific markers of classical complement pathway activation. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:35 / 45
页数:11
相关论文
共 36 条
[1]   Structural and functional studies on C1r and C1s: New insights into the mechanisms involved in C1 activity and assembly [J].
Arlaud, GJ ;
Rossi, V ;
Thielens, NM ;
Gaboriaud, C ;
Bersch, B ;
Hernandez, JF .
IMMUNOBIOLOGY, 1998, 199 (02) :303-316
[2]  
Bruins P, 1997, CIRCULATION, V96, P3542
[3]   The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex [J].
Budayova-Spano, M ;
Lacroix, M ;
Thielens, NM ;
Arlaud, GJ ;
Fontecilla-Camps, JC ;
Gaboriaud, C .
EMBO JOURNAL, 2002, 21 (03) :231-239
[4]   ACTIVATION OF C1 [J].
COLOMB, MG ;
ARLAUD, GJ ;
VILLIERS, CL .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1984, 306 (1129) :283-292
[5]   CLEARANCE OF HUMAN NATIVE, PROTEINASE-COMPLEXED, AND PROTEOLYTICALLY INACTIVATED C1-INHIBITOR IN RATS [J].
DESMET, BJGL ;
DEBOER, JP ;
AGTERBERG, J ;
RIGTER, G ;
BLEEKER, WK ;
HACK, CE .
BLOOD, 1993, 81 (01) :56-61
[6]   ISOTYPES OF MOUSE IGG .1. EVIDENCE FOR NON-COMPLEMENT-FIXING IGG1 ANTIBODIES AND CHARACTERIZATION OF THEIR CAPACITY TO INTERFERE WITH IGG2 SENSITIZATION OF TARGET RED-BLOOD-CELLS FOR LYSIS BY COMPLEMENT [J].
EY, PL ;
RUSSELLJONES, GJ ;
JENKIN, CR .
MOLECULAR IMMUNOLOGY, 1980, 17 (06) :699-710
[7]  
Gadjeva M, 1998, J IMMUNOL, V161, P985
[8]   The mannan-binding-lectin pathway of the innate immune response [J].
Gadjeva, M ;
Thiel, S ;
Jensenius, JC .
CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (01) :74-78
[9]  
GUAN E, 1991, J BIOL CHEM, V266, P20345
[10]  
HACK CE, 1988, J IMMUNOL, V141, P1602